Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
10
×
health
10
×
tc
startups
artificial intelligence
funding
fundings & exits
recent funding
food and drug administration
johnson & johnson
machine learning
medical tech
acacia venture capital partners
ajay royan
anjie liu
arch venture partners
bill martin
bio
biology
biotech & health
biotechnology
blood testing
capsule
ceo
chemicals
computer vision
david hachuel
diagnostics
diets
digital therapeutics
dna
drug development
ecommerce
endeavor
europe
events
executive
fda
food
frederic moll
What
company
10
×
medical
million
based
series
startup
approach
betting
called
closed
create
developed
diagnostics
digital
fda
focused
founder
free
gets
health
lead
machine
medicine
new
round
technology
that’s
today
treat
using
women’s
acquired
acquires
acquisition
additionally
aims
ai’s
ajay
algorithms
alison
Language
unset
Current search:
company
×
health
×
biotech
×
@techcrunch.com
1 year ago
Nanopath is looking to drastically change medical diagnostics
@techcrunch.com
2 years ago
Sirona Medical Acquires Nines AI’s algorithms to rebuild radiology’s IT from the ground up
@techcrunch.com
2 years ago
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
@techcrunch.com
2 years ago
Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@techcrunch.com
3 years ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@techcrunch.com
5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas